Profil
Paul Rowan is the founder of NoviSci, Inc. He held the title of Principal Software Architect at the company.
Postes actifs de Paul Rowan
| Sociétés | Poste | Début |
|---|---|---|
NoviSci, Inc.
 NoviSci, Inc. Data Processing ServicesTechnology Services Part of TARGET PharmaSolutions, Inc., NoviSci, Inc. is a company that uses principled data science to improve population health outcomes for vulnerable patients with complex conditions. The company is based in Durham, NC. The company's novel analytic applications facilitate the efficient deployment of complex research methods from epidemiology and statistics as well as intuitive, interactive visualization of complex results from real-world studies. NoviSci's founders and leaders continue to hold faculty appointments, including at the Duke University School of Medicine and the University of North Carolina at Chapel Hill. The company was founded by Alan M. Brookhart, Paul Rowan, Aaron McKethan. Aaron McKethan has been the CEO since incorporation. NoviSci was acquired by TARGET PharmaSolutions, Inc. on January 15, 2021. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
NoviSci, Inc.
NoviSci, Inc. Data Processing ServicesTechnology Services Part of TARGET PharmaSolutions, Inc., NoviSci, Inc. is a company that uses principled data science to improve population health outcomes for vulnerable patients with complex conditions. The company is based in Durham, NC. The company's novel analytic applications facilitate the efficient deployment of complex research methods from epidemiology and statistics as well as intuitive, interactive visualization of complex results from real-world studies. NoviSci's founders and leaders continue to hold faculty appointments, including at the Duke University School of Medicine and the University of North Carolina at Chapel Hill. The company was founded by Alan M. Brookhart, Paul Rowan, Aaron McKethan. Aaron McKethan has been the CEO since incorporation. NoviSci was acquired by TARGET PharmaSolutions, Inc. on January 15, 2021. | Technology Services |
